MAPT and Alzheimer disease: Some studies have indicated that CSF p-tau202 is inversely associated with Aβ-PET, and the phosphorylation rate decreases with disease severity [6, 8], whereas others have shown increases along the AD continuum and positive correlations with Aβ and tau-PET [13].